Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices

This publication has 36 references indexed in Scilit:

• Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure
  Journal of the American College of Cardiology, 2007
• Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure
  Heart Failure Reviews, 2006
• Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure
  New England Journal of Medicine, 2006
• Cardiac biomarkers: a contemporary status report
  Nature Clinical Practice Cardiovascular Medicine, 2006
• CardioWest Total Artificial Heart: Bad Oeynhausen Experience
  The Annals of Thoracic Surgery, 2005
• Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart
  Circulation, 2005
• Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems
  Journal of the American College of Cardiology, 2001
• The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types
  The Journal of Heart and Lung Transplantation, 2001
• ABC of heart failure: History and epidemiology
  BMJ, 2000
• Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated Cardiomyopathy
  Circulation, 1997